Literature DB >> 1119787

Split ileostomy in the treatment of Crohn's disease of the colon.

E Lee.   

Abstract

Because of the problems associated with surgical resection of Crohn's disease of the colon a more conservative approach has been used in Oxford since 1960. The inflamed large bowel has been defunctioned by an external diversionary ileostomy and subsequently the disease has been treated with topical and oral corticosteroids. The technique of the split ileostomy used for this purpose is described and the indications for the operation and early results of its use in 69 patients are recorded. In carefully chosen cases the method has two advantages over primary resection. In some patients the inflammation improved sufficiently for continuity of the bowel to be restored without resection being necessary and without medical treatment being required. In others the ileostomy resulted in a marked improvement in general health which has made the subsequent major resection a safer procedure. As an extension of the technique the use of an external faecal diversion by ileostomy is recorded in a further 11 patients who had a synchronous resection of a segment of bowel affected by Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1119787      PMCID: PMC2388503     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  3 in total

1.  PLACE OF A DOUBLE-BARRELLED ILEOSTOMY IN ULCERATIVE COLITIS AND CROHN'S DISEASE OF THE COLON: A PRELIMINARY REPORT.

Authors:  S C TRUELOVE; H ELLIS; C U WEBSTER
Journal:  Br Med J       Date:  1965-01-16

2.  The management of an ileostomy, including its complications.

Authors:  B N BROOKE
Journal:  Lancet       Date:  1952-07-19       Impact factor: 79.321

3.  Loop ileostomy and colostomy for faecal diversion.

Authors:  J Alexander-Williams
Journal:  Ann R Coll Surg Engl       Date:  1974-03       Impact factor: 1.891

  3 in total
  9 in total

Review 1.  Management of perianal Crohn's disease.

Authors:  A Allan; M R Keighley
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

2.  Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process.

Authors:  M C Winslet; A Allan; V Poxon; D Youngs; M R Keighley
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

3.  Loop illeostomy in the management of Crohn's colitis in the debilitated patient.

Authors:  P Zelas; D G Jagelman
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

4.  Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice.

Authors:  E F Verdù; P Bercik; B Cukrowska; M A Farre-Castany; H Bouzourene; E Saraga; A L Blum; I Corthésy-Theulaz; H Tlaskalova-Hogenova; P Michetti
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

5.  Role of the faecal stream in the maintenance of Crohn's colitis.

Authors:  P H Harper; E C Lee; M G Kettlewell; M K Bennett; D P Jewell
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

6.  Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey.

Authors:  P H Harper; S C Truelove; E C Lee; M G Kettlewell; D P Jewell
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

7.  Factors which influenced postoperative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids.

Authors:  J R Allsop; E C Lee
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

Review 8.  Perianal Crohn's disease: challenges and solutions.

Authors:  Katherine A Kelley; Taranjeet Kaur; Vassiliki L Tsikitis
Journal:  Clin Exp Gastroenterol       Date:  2017-02-08

9.  Temporary fecal diversion in the management of colorectal and perianal Crohn's disease.

Authors:  Rudolf Mennigen; Britta Heptner; Norbert Senninger; Emile Rijcken
Journal:  Gastroenterol Res Pract       Date:  2015-01-11       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.